Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 241


The Dutch-Flemish PROMIS Physical Function item bank exhibited strong psychometric properties in patients with chronic pain.

Crins MHP, Terwee CB, Klausch T, Smits N, de Vet HCW, Westhovens R, Cella D, Cook KF, Revicki DA, van Leeuwen J, Boers M, Dekker J, Roorda LD.

J Clin Epidemiol. 2017 Mar 28. pii: S0895-4356(16)30364-X. doi: 10.1016/j.jclinepi.2017.03.011. [Epub ahead of print]


A Rare Cause of Weight Loss in an 80y Old Ankylosing Spondylitis Patient.

Westhovens I, Thielens I, De Vlam K, Westhovens R, Delva T.

J Clin Rheumatol. 2017 Apr;23(3):170-171. doi: 10.1097/RHU.0000000000000505. No abstract available.


EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6.


Diverging illness perceptions between physicians about patients with systemic lupus erythematosus and systemic sclerosis: a vignette-based study.

Arat S, Moons P, Vandenberghe J, Lenaerts JL, de Vlam K, Westhovens R.

Rheumatol Int. 2017 Jun;37(6):915-922. doi: 10.1007/s00296-017-3667-8. Epub 2017 Feb 28.


Accelerometry-Based Activity Recognition and Assessment in Rheumatic and Musculoskeletal Diseases.

Billiet L, Swinnen TW, Westhovens R, de Vlam K, Van Huffel S.

Sensors (Basel). 2016 Dec 16;16(12). pii: E2151. doi: 10.3390/s16122151.


Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1).

Westhovens R, Taylor PC, Alten R, Pavlova D, Enríquez-Sosa F, Mazur M, Greenwald M, Van der Aa A, Vanhoutte F, Tasset C, Harrison P.

Ann Rheum Dis. 2017 Jun;76(6):998-1008. doi: 10.1136/annrheumdis-2016-210104. Epub 2016 Dec 19.


A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.

De Mits S, Lenaerts J, Vander Cruyssen B, Mielants H, Westhovens R, Durez P, Elewaut D; Be-Raise study group.

PLoS One. 2016 Nov 28;11(11):e0166607. doi: 10.1371/journal.pone.0166607. eCollection 2016.


A Review of Persuasive Principles in Mobile Apps for Chronic Arthritis Patients: Opportunities for Improvement.

Geuens J, Swinnen TW, Westhovens R, de Vlam K, Geurts L, Vanden Abeele V.

JMIR Mhealth Uhealth. 2016 Oct 13;4(4):e118.


Costs of drugs for treatment of rheumatic diseases.

Westhovens R, Annemans L.

RMD Open. 2016 Sep 12;2(2):e000259. doi: 10.1136/rmdopen-2016-000259. eCollection 2016.


Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.


Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.

Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18.


Instrumented BASFI (iBASFI) Shows Promising Reliability and Validity in the Assessment of Activity Limitations in Axial Spondyloarthritis.

Swinnen TW, Milosevic M, Van Huffel S, Dankaerts W, Westhovens R, de Vlam K.

J Rheumatol. 2016 Aug;43(8):1532-40. doi: 10.3899/jrheum.150439. Epub 2016 Jun 15.


Development and preliminary evaluation of the validity and reliability of a revised illness perception questionnaire for healthcare professionals.

Arat S, Van den Zegel A, Van Rillaer M, Moons P, Vandenberghe J, De Langhe E, Westhovens R.

BMC Nurs. 2016 Jun 1;15:34. doi: 10.1186/s12912-016-0156-4. eCollection 2016.


Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?

Verschueren P, Westhovens R.

Ann Rheum Dis. 2016 Jun;75(6):947-9. doi: 10.1136/annrheumdis-2015-208863. Epub 2016 Feb 9. No abstract available.


Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study.

van der Elst K, Meyfroidt S, De Cock D, De Groef A, Binnard E, Moons P, Verschueren P, Westhovens R.

Arthritis Care Res (Hoboken). 2016 Sep;68(9):1278-87. doi: 10.1002/acr.22824. Epub 2016 Jul 29.


A general practice perspective on early rheumatoid arthritis management: A qualitative study from Flanders.

Meyfroidt S, Stevens J, De Lepeleire J, Westhovens R, De Cock D, Van der Elst K, Vanhaecht K, Verschueren P.

Eur J Gen Pract. 2015;21(4):231-7. doi: 10.3109/13814788.2015.1084279. Epub 2015 Nov 19.


Patients' Perceptions of their Rheumatic Condition: Why Does it Matter and How Can Healthcare Professionals Influence or Deal with these Perceptions?

Arat S, Vandenberghe J, Moons P, Westhovens R.

Musculoskeletal Care. 2016 Sep;14(3):174-9. doi: 10.1002/msc.1128. Epub 2015 Dec 8. No abstract available.


Are illness perception and coping style associated with the delay between symptom onset and the first general practitioner consultation in early rheumatoid arthritis management? An exploratory study within the CareRA trial.

Van der Elst K, De Cock D, Vecoven E, Arat S, Meyfroidt S, Joly J, Moons P, Verschueren P, Westhovens R, CareRA Study Group.

Scand J Rheumatol. 2016;45(3):171-8. doi: 10.3109/03009742.2015.1074278. Epub 2015 Sep 23.


Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease.

Vrancken A, De Langhe E, Westhovens R, Yserbyt J, Cottin V, Wuyts W.

Respirol Case Rep. 2015 Sep;3(3):99-101. doi: 10.1002/rcr2.113. Epub 2015 Jun 8.


The clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: results of the DON'T RETARD project.

Hilderson D, Moons P, Van der Elst K, Luyckx K, Wouters C, Westhovens R.

Rheumatology (Oxford). 2016 Jan;55(1):133-42. doi: 10.1093/rheumatology/kev284. Epub 2015 Aug 28.


Supplemental Content

Loading ...
Support Center